{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:27:26Z","timestamp":1762522046829,"version":"3.41.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.dld.2017.06.004","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T12:30:38Z","timestamp":1498221038000},"page":"1298-1305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts"],"prefix":"10.1016","volume":"49","author":[{"given":"Alessandro","family":"Armuzzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Felice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ennio","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Cantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Castiglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Gionchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambrogio","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Salvarani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Marchesoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Vecchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignazio","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2017.06.004_bib0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.42.3.387","article-title":"Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history","volume":"42","author":"Orchard","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.06.004_bib0010","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/003655201317097173","article-title":"Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients","volume":"36","author":"Salvarani","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.004_bib0015","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00296-005-0044-9","article-title":"The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease","volume":"26","author":"Turkcapar","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.dld.2017.06.004_bib0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1155\/2013\/139702","article-title":"Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease","volume":"27","author":"Stolwijk","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.004_bib0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/ecco-jcc\/jjv195","article-title":"Classifying back pain and peripheral joint complaints in inflammatory bowel disease patients: a prospective longitudinal follow-up study","volume":"10","author":"Van Erp","year":"2016","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2017.06.004_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dld.2010.07.010","article-title":"The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: the use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease","volume":"43","author":"Orlando","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2017.06.004_bib0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crohns.2009.12.002","article-title":"The second European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease: current management","volume":"4","author":"Dignass","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2017.06.004_bib0040","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.crohns.2012.09.002","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management","volume":"6","author":"Dignass","year":"2012","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2017.06.004_bib0045","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2011.151563","article-title":"2010 update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis","volume":"70","author":"Van Der Heijde","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.dld.2017.06.004_bib0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/annrheumdis-2011-200350","article-title":"European league against rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies","volume":"71","author":"Gossec","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.dld.2017.06.004_bib0055","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.autrev.2014.04.003","article-title":"Italian expert panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease","volume":"13","author":"Olivieri","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.dld.2017.06.004_bib0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.crohns.2009.12.003","article-title":"The second European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease: definitions and diagnosis","volume":"4","author":"Van Assche","year":"2010","journal-title":"J Crohn\u2019s Colitis"},{"key":"10.1016\/j.dld.2017.06.004_bib0065","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.crohns.2012.09.003","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: definitions and diagnosis","volume":"6","author":"Dignass","year":"2012","journal-title":"J Crohn\u2019s Colitis"},{"key":"10.1016\/j.dld.2017.06.004_bib0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.autrev.2013.06.002","article-title":"Optimizing anti-TNF treatments in inflammatory bowel disease","volume":"13","author":"Ben-Horin","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"Suppl. 2","key":"10.1016\/j.dld.2017.06.004_bib0075","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.dld.2017.06.004_bib0080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","article-title":"Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.dld.2017.06.004_bib0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/art.20926","article-title":"Recommendations for musculoskeletal ultrasonography by rheumatologists: setting global standards for best practice by expert consensus","volume":"53","author":"Brown","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.dld.2017.06.004_bib0090","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S1470-2045(11)70215-7","article-title":"Consensus-based standards for best supportive care in clinical trials in advanced cancer","volume":"13","author":"Zafar","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.dld.2017.06.004_bib0095","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1378\/chest.09-1543","article-title":"American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease","volume":"137","author":"Mahler","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.dld.2017.06.004_bib0100","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2017.06.004_bib0105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","article-title":"Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn\u2019s disease: the CLASSIC-I trial","volume":"130","author":"Hanauer","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.06.004_bib0110","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2006.106781","article-title":"Adalimumab for maintenance treatment of Crohn\u2019s disease: results of the CLASSIC II trial","volume":"56","author":"Sandborn","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.06.004_bib0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.gastro.2011.10.032","article-title":"Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis","volume":"142","author":"Sandborn","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.06.004_bib0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.gastro.2013.05.048","article-title":"Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis","volume":"146","author":"Sandborn","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.06.004_bib0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2013.06.010","article-title":"Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis","volume":"146","author":"Sandborn","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.06.004_bib0130","unstructured":"Remicade Summary of Product Characteristics [online]. Accessed June 07, 2017. Available at http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR__Product_Information\/human\/000240\/WC500050888.pdf."},{"key":"10.1016\/j.dld.2017.06.004_bib0135","first-page":"CD000544","article-title":"Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis","volume":"10","author":"Feagan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2017.06.004_bib0140","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cgh.2005.12.002","article-title":"Safety of celecoxib in patients with ulcerative colitis in remission: a randomised placebo controlled pilot study","volume":"4","author":"Sandborn","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2017.06.004_bib0145","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1572-0241.2006.00384.x","article-title":"The gastrointestinal safety and effect on disease activity of etoricoxib, a selective COX-2 inhibitor in inflammatory bowel diseases","volume":"101","author":"El Miedany","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.004_bib0150","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","article-title":"2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"70","author":"Braun","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.dld.2017.06.004_bib0155","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.semarthrit.2014.09.012","article-title":"Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: a systematic review","volume":"44","author":"Lubrano","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.dld.2017.06.004_bib0160","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/rheumatology\/kem247","article-title":"Effectiveness of rehabilitation in active ankylosing spondylitis assessed by the ASAS response criteria","volume":"46","author":"Lubrano","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.dld.2017.06.004_bib0165","first-page":"2029","article-title":"Effects of a combination treatment of an intensive rehabilitation program and etanercept in patients with ankylosing spondylitis: a pilot study","volume":"33","author":"Lubrano","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.dld.2017.06.004_bib0170","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.autrev.2012.08.013","article-title":"Can we reduce the dosage of biologics in spondyloarthritis?","volume":"12","author":"Olivieri","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.dld.2017.06.004_bib0175","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/rheumatology\/kes059","article-title":"Methotrexate in peripheral spondyloarthritis including psoriatic arthritis: a need for further evaluation","volume":"51","author":"Dougados","year":"2012","journal-title":"Rheumatology (Oxford)"},{"year":"1962","series-title":"An experimental application of the Delphi method to the use of experts. Publication RM-727-PR","author":"Dalkey","key":"10.1016\/j.dld.2017.06.004_bib0180"},{"key":"10.1016\/j.dld.2017.06.004_bib0185","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","article-title":"Research guidelines for the Delphi survey technique","volume":"32","author":"Hasson","year":"2000","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.dld.2017.06.004_bib0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00005110-199805000-00002","article-title":"Nursing administration research priorities: a national Delphi study","volume":"28","author":"Lynn","year":"1998","journal-title":"J Nurs Adm"},{"key":"10.1016\/j.dld.2017.06.004_bib0195","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1287\/mnsc.9.3.458","article-title":"Delphi technique: characteristics and sequence model to the use of experts","volume":"9","author":"Dalkey","year":"1963","journal-title":"Manage Sci"},{"key":"10.1016\/j.dld.2017.06.004_bib0200","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1365-2648.1994.tb01207.x","article-title":"The Delphi technique: a worthwhile research approach for nursing?","volume":"19","author":"McKenna","year":"1994","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.dld.2017.06.004_bib0205","doi-asserted-by":"crossref","first-page":"I","DOI":"10.3310\/hta2030","article-title":"Consensus development methods, and their use in clinical guideline development","volume":"2","author":"Murphy","year":"1998","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.dld.2017.06.004_bib0210","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1365-2648.2003.02537.x","article-title":"The Delphi technique: myths and realities","volume":"41","author":"Powell","year":"2003","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.dld.2017.06.004_bib0215","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/00019053-199712020-00003","article-title":"The use of consensus methods and expert panels in pharmacoeconomic studies. Practical applications and methodological shortcomings","volume":"12","author":"Evans","year":"1997","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.dld.2017.06.004_bib0220","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"Br Med J"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817309349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817309349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T23:47:11Z","timestamp":1750376831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865817309349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1590865817309349"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2017.06.004","relation":{},"ISSN":["1590-8658"],"issn-type":[{"type":"print","value":"1590-8658"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2017.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}